Official Statistics

Antenatal screening standards: data report 2019 to 2020

Data report for fetal anomaly screening, infectious diseases in pregnancy screening and sickle cell and thalassaemia screening 1 April 2019 to 31 March 2020.

Applies to England

Documents

FASP standards data 2019 to 2020

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

IDPS standards data 2019 to 2020

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

SCT standards data 2019 to 2020

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Recommendations for providers

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This publication covers the 3 NHS population antenatal screening programmes. These are the:

  • NHS Fetal Anomaly Screening Programme (FASP)
  • NHS Infectious Diseases in Pregnancy Screening (IDPS) Programme
  • NHS Sickle Cell and Thalassaemia (SCT) Screening Programme

Antenatal screening covers 17 different conditions and is offered to approximately 700,000 pregnant women in England every year.

Main facts

The report shows that:

  • coverage for antenatal SCT screening has steadily increased since 2014 to 2015 and is now at 99.7%
  • coverage has remained stable since 2016 to 2017 and is now at 99.8% for HIV, hepatitis B and syphilis screening in 2019 to 2020
  • in addition to antenatal screening for sickle cell and thalassaemia, 620,000 newborn babies were screened for sickle cell disease
  • as part of fetal anomaly screening, 98.1% of women with higher chance results were offered an appointment within 3 working days
  • of those babies requiring hepatitis B vaccination, 98.5% received their first dose within 24 hours

Contact the PHE Screening helpdesk with any queries about this publication, making sure you include its full title.

Updates to this page

Published 27 July 2021

Sign up for emails or print this page